Open access · CC-BY
via OpenAlex
Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis
Li Zhang, Jianhua Li, Huilu Zhang, Qi Qin, Yichen Huang, Xiaofan Tian, Chao Sun, Binbin Li, Zhengxin Wang, Xin Zhang
Advanced Science · 2026
Abstract
Despite extensive research, the etiology of metabolic dysfunction-associated steatotic liver disease (MASLD) remains incompletely understood. Through analysis of single-cell RNA sequencing (scRNA-seq) data from murine and human MASLD models, we identify a lipid-associated hepatocyte population and implicate Rab1A as its prominent player. Both global knockout and liver-specific knockdown of Rab1A mitigate western diet-induced hepatic steatosis in adult mice. We further show that knockdown of Rab1A in hepatic cells attenuates lipid accumulation by inducing excessive mitophagy. Mechanistically, Rab1A suppresses Raf-1 activation, thereby inhibiting the MEK/ERK1/2 signaling cascade. Pharmacological inhibition of MEK/ERK1/2 via U0126 reverses lipid depletion and restores mitophagy attenuation in Rab1A-deficient cells. We further demonstrate that ERK1/2 directly interacts with and phosphorylates PINK1 at Ser228, triggering PINK1-Parkin-dependent mitophagy. Critically, pharmacological activation of mitophagy by Urolithin A, or by C16-PAF used as a research tool to engage the ERK1/2/PINK1-Parkin axis, alleviates high-fat diet-induced hepatic steatosis and attenuates MASLD progression in mice. In human MASLD patients, Rab1A expression inversely correlates with activation of the Raf-1/ERK1/2/PINK1 pathway. Collectively, our findings identify the Rab1A/Raf-1/ERK1/2/PINK1 axis as a key regulator of mitophagy and MASLD pathogenesis, and highlight this pathway as a promising target for future therapeutic development.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/advs.202517520
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Zhang, L., Li, J., Zhang, H., Qin, Q., Huang, Y., Tian, X., Sun, C., Li, B., Wang, Z., & Zhang, X. (2026). Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis. <em>Advanced Science</em>. https://doi.org/10.1002/advs.202517520
Vancouver
Zhang L, Li J, Zhang H, Qin Q, Huang Y, Tian X, et al. Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis. Advanced Science. 2026. doi:10.1002/advs.202517520.
BibTeX
@article{li2026RabAPr,
title = {Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis},
author = {Li Zhang and Jianhua Li and Huilu Zhang and Qi Qin and Yichen Huang and Xiaofan Tian and Chao Sun and Binbin Li and Zhengxin Wang and Xin Zhang},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517520},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Biological Sciences 2022
Open access · CC-BY
Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2
Aging Cell 2023
Open access · CC-BY
Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution
International immunopharmacology 2026
Citation only
Paeonol mitigates age-related osteoporosis via mitophagy-mediated NLRP3 inflammasome inhibition.
Nature Communications 2024
Open access · CC-BY
Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging
Acta Pharmacologica Sinica 2022
Open access · OA
Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation
The Journal of nutritional biochemistry 2026
Citation only